Tag: FDA adverse event reporting
The FDA monitors generic drug safety after approval through real-time reporting, manufacturing data, and patient feedback. Learn how adverse events are tracked, what gaps exist, and what’s changing in 2025 to improve detection of quality and effectiveness issues.
Medications
Archives
Recent-posts
Pharmacist-Led Substitution Programs: How They Work and Why They Reduce Hospital Readmissions
Dec, 11 2025
Generic Drug Contamination Risks: How to Prevent and Respond to Unsafe Medications
Nov, 14 2025
How to Keep Your Medications Safe in Hotels and Hostels
Apr, 22 2026
Verapamil vs Other Antiarrhythmic Drugs: What You Need to Know
Nov, 18 2025
Crossover Trial Design: How Bioequivalence Studies Are Structured
Dec, 15 2025